January 23, 2026

Why Delayed-Release Matters for Digestive Supplements

BY MEDISYN LABS EDITORIAL TEAM

Educational content only. Not medical advice.

Oral formulations face a fundamental challenge: delivering active ingredients to the intended site of action within the digestive tract. The acidic environment of the stomach, with a pH typically ranging from 1.5 to 3.5, can degrade sensitive compounds before they reach their target location. Delayed-release technology addresses this challenge through specialized coating systems.

The Challenge of Gastric Degradation

The stomach's acidic environment serves an important physiological purpose, but it presents obstacles for certain oral formulations. Many active compounds are pH-sensitive and may be partially or fully degraded when exposed to gastric acid. This degradation can occur within minutes of ingestion, depending on the compound's chemical structure.

Additionally, some compounds may cause irritation to the stomach lining when released in the gastric environment. Formulation scientists must consider both the stability of the active ingredient and its interaction with gastric tissue when designing delivery systems.

How Delayed-Release Coatings Work

Delayed-release coatings are polymer-based barriers applied to tablets or capsules. These coatings remain intact in acidic conditions but dissolve when exposed to the higher pH environment of the small intestine, typically above pH 5.5 to 6.0.

Common coating materials include methacrylic acid copolymers, cellulose acetate phthalate, and hydroxypropyl methylcellulose phthalate. Each material has specific dissolution characteristics that determine where in the digestive tract the coating will break down.

Enteric Coating Technology

Enteric coatings are a specific type of delayed-release system designed to prevent dissolution in the stomach while allowing release in the intestine. The term "enteric" refers to the small intestine, where these coatings are engineered to dissolve.

The thickness and composition of the enteric coating determine its dissolution profile. Thicker coatings provide longer gastric resistance but may delay intestinal release. Formulation scientists balance these factors based on the specific requirements of each application.

Factors Affecting Release Timing

Several variables influence when a delayed-release formulation will begin releasing its contents. Gastric emptying time varies between individuals and is affected by meal composition, volume, and individual physiology. Fasting states generally result in faster gastric transit than fed states.

The pH transition between stomach and intestine is not instantaneous. As contents move through the pylorus into the duodenum, they encounter a gradual pH increase as pancreatic bicarbonate neutralizes gastric acid. Coating dissolution occurs progressively as pH rises.

Quality Control in Manufacturing

Pharmaceutical and nutraceutical manufacturers use standardized testing methods to verify delayed-release performance. Dissolution testing in sequential media—first acidic, then neutral—simulates the gastric-to-intestinal transition and measures the rate of active ingredient release.

Specifications typically require that less than 10% of the contents release during the acidic phase, with the majority releasing within a defined time window after pH transition. These parameters ensure consistent performance across production batches.

Considerations for Formulation Design

The decision to use delayed-release technology depends on the physicochemical properties of the active ingredient, its intended site of action, and its interaction with digestive physiology. Not all oral formulations require delayed release; many compounds are stable in gastric conditions and absorb effectively from the stomach or upper intestine.

For compounds that do require protection from gastric acid, delayed-release coatings represent one approach within a broader toolkit of formulation strategies. Other options include buffering systems, microencapsulation, and modified-release matrices.

To understand more about digestive processes and nutrient absorption, see our article on How Bile Works in Fat Digestion.

Gallavance™ Original uses DRcaps® delayed-release capsules to deliver ox bile, lipase, and phosphatidylcholine past the stomach. Gallavance™ Plant-Based offers a fully vegan alternative with the same delayed-release technology.

This article is for educational purposes only and provides general information about pharmaceutical and nutraceutical formulation technology. It is not intended as product-specific guidance or medical advice.

---

Back to blog